ADAM17-Mediated Shedding of Inflammatory Cytokines in Hypertension
Document Type
Article
Publication Date
7-29-2020
Publication Title
Frontiers in Pharmacology
Abstract
The increase of Angiontesin-II (Ang-II), one of the key peptides of the renin-angiotensin system (RAS), and its binding to the Ang-II type 1 receptor (AT1R) during hypertension is a crucial mechanism leading to AD\AM17 activation. Among the reported membrane anchored proteins cleaved by ADAM17, immunological cytokines (TNF-α, IFN-γ, TGF-β, IL-4, IL-10, IL-13, IL-6, FKN) are the major class of substrates, modulation of which triggers inflammation. The rise in ADAM17 levels has both central and peripheral implications in inflammation-mediated hypertension. This narrative review provides an overview of the role of ADAM17, with a special focus on its cellular regulation on neuronal and peripheral inflammation-mediated hypertension. Finally, it highlights the importance of ADAM17 with regards to the biology of inflammatory cytokines and their roles in hypertension.
PubMed ID
32848763
Volume
11
Recommended Citation
de Queiroz, Thyago M.; Lakkappa, Navya; and Lazartigues, Eric, "ADAM17-Mediated Shedding of Inflammatory Cytokines in Hypertension" (2020). School of Medicine Faculty Publications. 1973.
https://digitalscholar.lsuhsc.edu/som_facpubs/1973
10.3389/fphar.2020.01154